IL112642A - Mammalian cell-cycle protein - Google Patents

Mammalian cell-cycle protein

Info

Publication number
IL112642A
IL112642A IL11264295A IL11264295A IL112642A IL 112642 A IL112642 A IL 112642A IL 11264295 A IL11264295 A IL 11264295A IL 11264295 A IL11264295 A IL 11264295A IL 112642 A IL112642 A IL 112642A
Authority
IL
Israel
Prior art keywords
p55cdc
ser
polypeptide
ala
cell
Prior art date
Application number
IL11264295A
Other languages
English (en)
Other versions
IL112642A0 (en
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of IL112642A0 publication Critical patent/IL112642A0/xx
Publication of IL112642A publication Critical patent/IL112642A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL11264295A 1994-02-14 1995-02-14 Mammalian cell-cycle protein IL112642A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19573094A 1994-02-14 1994-02-14

Publications (2)

Publication Number Publication Date
IL112642A0 IL112642A0 (en) 1995-05-26
IL112642A true IL112642A (en) 2001-11-25

Family

ID=22722553

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11264295A IL112642A (en) 1994-02-14 1995-02-14 Mammalian cell-cycle protein

Country Status (12)

Country Link
US (2) US6291642B1 (ja)
EP (1) EP0745124B1 (ja)
JP (1) JP3064012B2 (ja)
AT (1) ATE167518T1 (ja)
AU (1) AU700350B2 (ja)
CA (1) CA2183254A1 (ja)
DE (1) DE69503038T2 (ja)
DK (1) DK0745124T3 (ja)
ES (1) ES2117855T3 (ja)
GR (1) GR3027621T3 (ja)
IL (1) IL112642A (ja)
WO (1) WO1995021917A1 (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0745124B1 (en) * 1994-02-14 1998-06-17 Amgen Inc. Mammalian cell cycle protein
US6074819A (en) * 1996-05-02 2000-06-13 Cold Spring Harbor Laboratory DNA replication-regulating genes
US5851821A (en) * 1996-05-02 1998-12-22 Cold Spring Harbor Laboratory DNA Replication-regulating genes
US6361954B1 (en) 1996-05-02 2002-03-26 Cold Spring Harbor Laboratory Methods of immunoassay for human CDC6
FR2779433B1 (fr) * 1998-06-08 2002-08-16 Centre Nat Rech Scient Proteine vegetale a motifs wd40 repetes, acide nucleique codant pour ladite proteine, et leurs applications
WO2006006948A2 (en) 2002-11-14 2006-01-19 Dharmacon, Inc. METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
US9879266B2 (en) 2002-11-14 2018-01-30 Thermo Fisher Scientific Inc. Methods and compositions for selecting siRNA of improved functionality
US7781575B2 (en) 2002-11-14 2010-08-24 Dharmacon, Inc. siRNA targeting tumor protein 53 (p53)
US7951935B2 (en) 2002-11-14 2011-05-31 Dharmacon, Inc. siRNA targeting v-myc myelocytomatosis viral oncogene homolog (MYC)
US7619081B2 (en) * 2002-11-14 2009-11-17 Dharmacon, Inc. siRNA targeting coatomer protein complex, subunit beta 2 (COPB2)
US9719094B2 (en) 2002-11-14 2017-08-01 Thermo Fisher Scientific Inc. RNAi targeting SEC61G
US20100113307A1 (en) * 2002-11-14 2010-05-06 Dharmacon, Inc. siRNA targeting vascular endothelial growth factor (VEGF)
US7691998B2 (en) * 2002-11-14 2010-04-06 Dharmacon, Inc. siRNA targeting nucleoporin 62kDa (Nup62)
US20090227780A1 (en) * 2002-11-14 2009-09-10 Dharmacon, Inc. siRNA targeting connexin 43
US7592442B2 (en) * 2002-11-14 2009-09-22 Dharmacon, Inc. siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)
US20080268457A1 (en) * 2002-11-14 2008-10-30 Dharmacon, Inc. siRNA targeting forkhead box P3 (FOXP3)
US7612196B2 (en) * 2002-11-14 2009-11-03 Dharmacon, Inc. siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
US8198427B1 (en) 2002-11-14 2012-06-12 Dharmacon, Inc. SiRNA targeting catenin, beta-1 (CTNNB1)
US9839649B2 (en) 2002-11-14 2017-12-12 Thermo Fisher Scientific Inc. Methods and compositions for selecting siRNA of improved functionality
US7635770B2 (en) * 2002-11-14 2009-12-22 Dharmacon, Inc. siRNA targeting protein kinase N-3 (PKN-3)
US7977471B2 (en) * 2002-11-14 2011-07-12 Dharmacon, Inc. siRNA targeting TNFα
US9771586B2 (en) 2002-11-14 2017-09-26 Thermo Fisher Scientific Inc. RNAi targeting ZNF205
US9719092B2 (en) 2002-11-14 2017-08-01 Thermo Fisher Scientific Inc. RNAi targeting CNTD2
US9228186B2 (en) 2002-11-14 2016-01-05 Thermo Fisher Scientific Inc. Methods and compositions for selecting siRNA of improved functionality
EP1560931B1 (en) 2002-11-14 2011-07-27 Dharmacon, Inc. Functional and hyperfunctional sirna
US10011836B2 (en) 2002-11-14 2018-07-03 Thermo Fisher Scientific Inc. Methods and compositions for selecting siRNA of improved functionality
US7605250B2 (en) * 2004-05-12 2009-10-20 Dharmacon, Inc. siRNA targeting cAMP-specific phosphodiesterase 4D
JP4131271B2 (ja) * 2005-03-30 2008-08-13 ソニー株式会社 情報処理装置および方法、並びにプログラム
US9799416B2 (en) * 2009-11-06 2017-10-24 Terrapower, Llc Methods and systems for migrating fuel assemblies in a nuclear fission reactor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4879213A (en) 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
EP0745124B1 (en) * 1994-02-14 1998-06-17 Amgen Inc. Mammalian cell cycle protein

Also Published As

Publication number Publication date
DK0745124T3 (da) 1999-02-01
US6673903B2 (en) 2004-01-06
CA2183254A1 (en) 1995-08-17
US20020035240A1 (en) 2002-03-21
US6291642B1 (en) 2001-09-18
EP0745124B1 (en) 1998-06-17
DE69503038T2 (de) 1999-03-25
ES2117855T3 (es) 1998-08-16
DE69503038D1 (de) 1998-07-23
WO1995021917A1 (en) 1995-08-17
GR3027621T3 (en) 1998-11-30
JPH09504959A (ja) 1997-05-20
ATE167518T1 (de) 1998-07-15
EP0745124A1 (en) 1996-12-04
IL112642A0 (en) 1995-05-26
AU1875695A (en) 1995-08-29
JP3064012B2 (ja) 2000-07-12
AU700350B2 (en) 1999-01-07

Similar Documents

Publication Publication Date Title
EP0745124B1 (en) Mammalian cell cycle protein
Weinstein et al. A novel mammalian protein, p55CDC, present in dividing cells is associated with protein kinase activity and has homology to the Saccharomyces cerevisiae cell division cycle proteins Cdc20 and Cdc4
EP0861894B1 (en) Differentiation-suppressive polypeptide
US20090175874A1 (en) Novel interleukin-1 receptor intracellular ligand proteins and inhibitors of ligand binding
JP2000517165A (ja) 新規な脂質キナーゼ
EA004309B1 (ru) Модуляторы связанного с рецептором tnf фактора (traf), их получение и применение
CA2148258A1 (en) Transcription factor dp-1
US6638741B2 (en) Differentiation-suppressive polypeptide serrate-2
US6077686A (en) Shc proteins
AU698575B2 (en) Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding
AU2001263952B2 (en) Tumour suppressor and uses thereof
WO1997032020A9 (en) Shc proteins
CA2219775A1 (en) Murine and human box-dependent myc-interacting protein (bin1) and uses therefor
CA2319782A1 (en) Retinoblastoma protein complexes and retinoblastoma interacting proteins
CA2360530C (en) A human nuclear protein having a ww domain and a polynucleotide encoding the protein
JP4059941B2 (ja) Ｒｈｏ標的タンパク質ｐ１４０ｍＤｉａ
US6355774B1 (en) Isolated p27 protein
US6444439B1 (en) Cloning and characterization of a cdc15-like adaptor protein (CD2BP1)
CA2365397A1 (en) Novel proteins, gene encoding the same and method of utilization thereof
RU2241747C2 (ru) Молекула днк, кодирующая полипептид, способный связываться с внутриклеточным доменом рецептора лиганда fas(fas-ic), полипептид, способ его получения, вектор, способ модуляции действия лиганда fas-r на клетки (варианты), фармацевтическая композиция (варианты), спрособ выделения и идентификации белка
JPH10286086A (ja) プロテインキナーゼｇａｋ、これをコードするｄｎａ配列、抗ｇａｋ抗体及びその産生細胞
CA2268457A1 (en) Mammalian rad1 genes, polypeptides and methods of use

Legal Events

Date Code Title Description
NP Permission for amending the patent specification granted (section 66, patents law 1967)

Free format text: JOURNAL NO. 9/2001 PAGE 2936, PATENT APPLICATION NO. 112642 THE CORRECT ADDRESS FOR SERVICE IS: SANFORD T. COLB & CO. P.O.B. 2273, REHOVOT AND NOT AS INDICATED.

KB Patent renewed
KB Patent renewed